<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ABSTRACT:: A 14 year-old Caucasian boy with idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (IIH) presented with <z:hpo ids='HP_0000622'>blurred vision</z:hpo> in his left eye </plain></SENT>
<SENT sid="1" pm="."><plain>Visual acuity was 20/20, right eye, and 20/80, left eye, and funduscopy revealed bilateral <z:hpo ids='HP_0001085'>papilledema</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, there was <z:e sem="disease" ids="C1282043" disease_type="Disease or Syndrome" abbrv="">peripapillary choroidal neovascular membrane</z:e> (PPCNVM) in the left eye </plain></SENT>
<SENT sid="3" pm="."><plain>Oral <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> improved the symptoms and signs of IIH, but seven weeks later, acuity remained 20/80, left eye, with an increase in subretinal <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Two weeks following an intravitreal injection of bevacizumab, visual acuity on the left had improved to 20/30 with resolution of subretinal <z:mp ids='MP_0001914'>hemorrhage</z:mp> and <z:mp ids='MP_0003045'>fibrosis</z:mp> of PPCNVM </plain></SENT>
<SENT sid="5" pm="."><plain>After an additional 2 weeks, visual acuity improved to 20/20, and there has been no sign of recurrence over 3.5 years of follow-up </plain></SENT>
</text></document>